These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1026140)

  • 21. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
    Debaert M; Ribet M; Quandalle P
    Lille Med; 1981 Mar; 26(3):140-3. PubMed ID: 7289750
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cerebrovascular disorders : facial thermography as a means to evaluate the therapeutic effectiveness of nicergoline].
    Sbarbaro V; Zardini GB; Morgante R; Mora L; Acciarri L; Pistolesi GF
    Farmaco Prat; 1976 Nov; 31(11):549-60. PubMed ID: 1017468
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and rheographic results of nicergoline in the treatment of arteritis of the lower extremities].
    Schrub JC; Courtois H; Philippe JC; Boismare F
    Therapie; 1975; 30(3):407-15. PubMed ID: 1224362
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of nicergoline on cerebral blood flow.
    Iliff LD; Du Boulay GH; Marshall J; Russell RW; Symon L
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):746-7. PubMed ID: 925694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical study on nicergoline in peripheral arteriopathies.
    Schönenberger F
    Farmaco Prat; 1976 Nov; 31(11):561-7. PubMed ID: 797575
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of nicergoline in the prevention of postoperative thrombophlebitis].
    Kauffmann JP; Keller D; Calderoli H; Ackermann E; Hollender LF
    Med Chir Dig; 1981; 10(2):169-72. PubMed ID: 7230952
    [No Abstract]   [Full Text] [Related]  

  • 28. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
    Battaglia A; Bruni G; Ardia A; Sacchetti G
    J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of nicergoline on the intellectual performance (author's transl)].
    Donoso A; Santander M; Sarce H
    Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nicergoline and severe isolated cranial injuries].
    Alibert F; Devaux C; Sauger F; Winckler C
    Agressologie; 1982; 23(E):93-8. PubMed ID: 7137483
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intravenous effect of nicergoline in arterial hypertension].
    Levenson JA; Roland E; Toto Mou Kouo J; Simon A; Safar M
    Rev Med Interne; 1980; 1(1):123-6. PubMed ID: 7232904
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use possibilities of quantitative electroencephalography in psychiatry and psychopharmacology].
    Fischer W; Rabending G; Heydenreich F; Herzer H; Altenstein R; Grimmberger E
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():124-36. PubMed ID: 7157108
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of nicergoline in acute myocardial infarction with diastolic hypertension.
    Triulzi E; Devizzi S; Margonato A
    Farmaco Prat; 1981 Oct; 36(10):449-55. PubMed ID: 7308417
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 35. Contingent negative variation and reaction time in patients with presenile idiopathic cognitive decline and presenile Alzheimer-type dementia. Preliminary report on long-term nicergoline treatment.
    Zappoli R; Arnetoli G; Paganini M; Versari A; Battaglia A; Grignani A; Sacchetti G
    Neuropsychobiology; 1987; 18(3):149-54. PubMed ID: 3453431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of an alpha-adrenergic blocking agent (nicergoline) in the treatment of diabetic angiopathy of lower limbs.
    Calvagno M
    Farmaco Prat; 1982 Jun; 37(6):200-5. PubMed ID: 7106277
    [No Abstract]   [Full Text] [Related]  

  • 37. [Favorable effect of nicergoline on pruritus in chronic hemodialysis patients. Role of a hyper-alpha-adrenergic system?].
    Rivory JP; Maheut H
    Presse Med; 1984 Dec; 13(44):2703. PubMed ID: 6096843
    [No Abstract]   [Full Text] [Related]  

  • 38. [Failure of nicergoline to control blood pressure in surgery of pheochromocytoma].
    Pinaud M; Arnould JF; Le Neel JC; Rodat O
    Ann Fr Anesth Reanim; 1983; 2(4):327-8. PubMed ID: 6650937
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke].
    Tsimenko OA; Sosnov IuD; Kharchenko AP; Gaĭduk IuS
    Vrach Delo; 1988 Jul; (7):24-7. PubMed ID: 3188456
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.